Physician

Sara Nausheen, MD

According to 2025 Medicare claims, Sara Nausheen, MD (NPI: 1821261256) practices infectious disease in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is ALTRU HEALTH SYSTEM (NPI: 1043309552; TIN: 450310462) and primary practice location at 58201-4036. Nausheen is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Nausheen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 385 traditional Medicare patients, billed 1,383 HCPCS/CPT codes, and received $106,931 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 462 prescription claims across 64 beneficiaries totaling $771,915 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2021 DME data shows 12 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $244,967 to $771,915. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,767 to $972.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	485	2,343	$134,496
2016	432	1,758	$96,777
2017	442	1,876	$102,667
2018	447	1,730	$96,242
2019	575	2,168	$155,232
2020	550	2,018	$146,242
2021	404	1,748	$126,624
2022	430	1,828	$126,433
2023	408	1,416	$112,271
2024	385	1,383	$106,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	269	1,688	$244,967
2016	210	1,732	$205,096
2017	265	1,972	$216,156
2018	265	1,989	$173,651
2019	198	1,885	$491,449
2020	133	926	$664,785
2021	86	608	$583,161
2022	85	681	$661,347
2023	90	600	$804,530
2024	64	462	$771,915

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	129	$1,524
2016	N/R	25	$231
2017	11	33	$346
2018	13	40	$411
2019	11	75	$1,089
2020	N/R	35	$1,096
2021	N/R	12	$913
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	292	354	$130
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	52	55	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	22	32	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	251	732	$59
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	102	145	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	66	1,980	$254,892
Cabenuva	Cabotegravir/Rilpivirine	28	1,626	$170,336
Tivicay	Dolutegravir Sodium	37	1,110	$108,856
Descovy	Emtricitabine/Tenofov Alafenam	30	900	$65,402
Vemlidy	Tenofovir Alafenamide	11	330	$15,881

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Sara Nausheen, MD?

Tedicare shows public-source Medicare data for Sara Nausheen, MD (NPI 1821261256), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sara Nausheen, MD have ACO affiliation data?

Sara Nausheen, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sara Nausheen, MD?

Sara Nausheen, MD is linked to ALTRU HEALTH SYSTEM (billing NPI 1043309552) in the available physician profile data.

Does Sara Nausheen, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.